Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary Dunne

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Health Behavior and Policy Review|September 1, 2020
A Pilot Intervention Targeting Dietary Intake in School CafeteriasSuzanne E Mazzeo, Melanie K Bean, Allison A Palmberg, et al.
BMC Urology|August 3, 2017
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapyDaniel N Cagney, Mary Dunne, Carmel O'Shea, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Unmasking anxiety: a head-to-head comparison of open and closed masks in head and neck cancer radiotherapyAisling M Glynn, Rachel Harwood, Bill Garrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancerAnthony V D'Amico, Ming-Hui Chen, Juanita Crook, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2023
Prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 3-Dimensional planning for endometrial cancerKillian Nugent, Darragh Browne, Mary Dunne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2018
Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancerRonan L McDermott, John G Armstrong, Pierre Thirion, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic diseaseAlina Mihai, Yijia Mu, John Armstrong, et al.
Frontiers in Oncology|March 14, 2025
Detection of radiosensitive subpopulations <i>ex-vivo</i> with Raman microspectroscopyAidan D Meade, Adrian Maguire, Jane Bryant, et al.
International Journal of Molecular Sciences|October 13, 2021
A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient RadiosensitivityOrla Howe, Lisa White, Daniel Cullen, et al.
International Journal of Radiation Biology|March 13, 2018
Prediction of DNA damage and G2 chromosomal radio-sensitivity ex vivo in peripheral blood mononuclear cells with label-free Raman micro-spectroscopyAidan D Meade, Adrian Maguire, Jane Bryant, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Health Behavior and Policy Review|September 1, 2020
A Pilot Intervention Targeting Dietary Intake in School CafeteriasSuzanne E Mazzeo, Melanie K Bean, Allison A Palmberg, et al.
BMC Urology|August 3, 2017
Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapyDaniel N Cagney, Mary Dunne, Carmel O'Shea, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|August 15, 2024
Unmasking anxiety: a head-to-head comparison of open and closed masks in head and neck cancer radiotherapyAisling M Glynn, Rachel Harwood, Bill Garrett, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2011
Duration of short-course androgen suppression therapy and the risk of death as a result of prostate cancerAnthony V D'Amico, Ming-Hui Chen, Juanita Crook, et al.
Acta Oncologica (Stockholm, Sweden)|July 26, 2023
Prospective randomised phase II trial evaluating adjuvant pelvic radiotherapy using either IMRT or 3-Dimensional planning for endometrial cancerKillian Nugent, Darragh Browne, Mary Dunne, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 18, 2018
Cancer Trials Ireland (ICORG) 06-34: A multi-centre clinical trial using three-dimensional conformal radiation therapy to reduce the toxicity of palliative radiation for lung cancerRonan L McDermott, John G Armstrong, Pierre Thirion, et al.
Journal of Radiosurgery and SBRT|January 4, 2018
Patients with colorectal lung oligometastases (L-OMD) treated by dose adapted SABR at diagnosis of oligometastatic disease have better outcomes than patients previously treated for their metastatic diseaseAlina Mihai, Yijia Mu, John Armstrong, et al.
Frontiers in Oncology|March 14, 2025
Detection of radiosensitive subpopulations <i>ex-vivo</i> with Raman microspectroscopyAidan D Meade, Adrian Maguire, Jane Bryant, et al.
International Journal of Molecular Sciences|October 13, 2021
A 4-Gene Signature of CDKN1, FDXR, SESN1 and PCNA Radiation Biomarkers for Prediction of Patient RadiosensitivityOrla Howe, Lisa White, Daniel Cullen, et al.
International Journal of Radiation Biology|March 13, 2018
Prediction of DNA damage and G2 chromosomal radio-sensitivity ex vivo in peripheral blood mononuclear cells with label-free Raman micro-spectroscopyAidan D Meade, Adrian Maguire, Jane Bryant, et al.
Pageof 5